Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Braveheart Bio(BRVE) the EBIT is -15.05 M (-151 times%);the EPS is -0.475 (--%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.02B15101.01%
----
----
EPS
-0.4751--
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf